Patent №
US 6,472,151
Granted
2002-10-29
Filed 1999
Owner
BRISTOL-MYERS SQUIBB COMPANY
Lab
—
AI components
1
hardware
Assignment
Recorded
Dataset
AIPD
2023_r1 edition
Application
09370847
The present invention provides a method for generating and isolating cell lines that functionally express molecular targets for drug discovery without utilizing information from the nucleic acid or amino acid sequence of the target protein. This procedure for the first time allows one to develop fast, high throughput screens for evaluation of test compounds that may modulate molecular targets whose specific nucleic acid or amino acid sequences are unavailable.
AI classification
Ownership
BRISTOL-MYERS SQUIBB COMPANY
assignment · 103850571
Assignors
WEAVER, C. DAVID, VERDOORN, TODD A., ROBINSON, GORDON W.
On an employer assignment, the assignors are typically the inventors.